Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$479.23M
Total Bought:
$54.98M
Total Sold:
$1.06M
Net Transaction:
+$53.91M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)8,118,5928,118,5920$115.53M$119.75M24.99%+$4.22M
Verona Pharma PlcADS1,436,8781,436,8780$66.73M$91.23M19.04%+$24.50M
Exelixis, Inc.(EXEL)1,525,7301,525,7300$50.81M$56.33M11.75%+$5.52M
Mineralys Therapeutics, Inc.(MLYS)1,011,1552,149,667+1,138,512$12.45M$34.14M7.12%+$21.69M
Evolus, Inc.(EOLS)2,692,3882,731,154+38,766$29.72M$32.86M6.86%+$3.13M
Sage Therapeutics Inc3,052,5383,052,5380$16.58M$24.27M5.06%+$7.69M
BioCryst Pharmaceuticals, Inc.(BCRX)2,995,9323,107,669+111,737$22.53M$23.31M4.86%+$778.1K
Anika Therapeutics Inc1,435,1301,435,1300$23.62M$21.57M4.50%-$2.05M
Agios Pharmaceuticals, Inc.(AGIO)626,280701,280+75,000$20.58M$20.55M4.29%-$32.1K
Revolution Medicines, Inc.(RVMD)0465,000+465,000$0$16.44M3.43%+$16.44M
Merus N V255,000376,954+121,954$10.72M$15.87M3.31%+$5.14M
Y-Mabs Therapeutics Inc1,767,9822,342,609+574,627$13.84M$10.38M2.17%-$3.47M
ABIVAX Société AnonymeADS(ABVX)752,1671,269,119+516,952$5.51M$7.93M1.66%+$2.43M
Verrica Pharmaceuticals Inc.(VRCA)7,429,6878,992,954+1,563,267$5.20M$3.98M0.83%-$1.22M
Rezolute, Inc.(RZLT)0141,309+141,309$0$409.8K0.09%+$409.8K
Tyra Biosciences, Inc.(TYRA)025,000+25,000$0$232.5K0.05%+$232.5K
Enanta Pharmaceuticals, Inc.(ENTA)184,8260-184,826$1.06M$0—-$1.06M
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q1 2025 | TickerTrail